Recombinant Viruses

A recombinant vaccine is a vaccine developed through recombinant DNA technology. Vaccine approaches to contagious diseases are widely applied and appreciated. Amongst them, vectors based on recombinant viruses have displayed great promise and play a crucial role in the instigation of new vaccinations. Many viruses have been examined for their ability to express proteins from foreign pathogens and induce specific immunological responses against these antigens in vivo. Generally, gene-based vaccines can trigger potent humoral and cellular immune responses and viral vectors might be an effective strategy for both the delivery of antigen-encoding genes and the facilitation and enhancement of antigen presentation.

Recent methods in the diagnosis of viral infections:

    Related Conference of Recombinant Viruses

    September 08-09, 2025

    45th Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    September 08-09, 2025

    6th International Conference on Vaccine Research

    Paris, France
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    October 06-07, 2025

    37th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada

    Recombinant Viruses Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in